Qiagen N.V.
Qiagen N.V. (QGEN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · QGEN · as of Jun 8, 2026
Key Statistics
Explore Qiagen N.V. Data
qgen stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 30 · Buy rate: 40.0%
The QGEN analyst consensus is Hold, based on ratings from 30 Wall Street analysts over the past 3 months. The average 12-month price target is $45.17, representing +23.15% upside from the current price of $36.68.
Competitors & Peers
qgen competitorsQGEN
ALGN
BAX
BMRN
CRL
ENSGStock Performance
Full HistoryAbout Qiagen N.V.
Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabil…
what is qiagen n.v. · qgen stock overview · qiagen n.v. company profile · who is qiagen n.v. ceo · qgen NYSE · qiagen n.v. headquarters · qiagen n.v. business segments
About Stock Overview & Key Data
Qiagen N.V. (QGEN) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Jun 28, 1996. As of the latest trading session, QGEN stock price is $36.68, with a market capitalization of $7.6B. The stock has returned -20.55% over the past 12 months and -22.52% year-to-date.
According to 30 Wall Street analysts, the consensus rating for Qiagen N.V. stock is Hold, with an average 12-month price target of $45.17. In fiscal year 2025, Qiagen N.V. reported revenue of $2.1B and net income of $424.9M. For detailed data — including Qiagen N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Qiagen N.V. (QGEN) stock price is $36.68. The stock is traded on NYSE under the ticker symbol QGEN. The 52-week range is $32.53 – $57.82.